Cara Therapeutics Inc (NASDAQ: CARA) Is Currently -607.58 Percent Below Its 52-Week High, But It Still Offers Strong Upside Potential.
Cara Therapeutics Inc (NASDAQ:CARA)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 0.76. At the close of